甲状腺乳头状癌中央区淋巴结转移的相关临床因素分析Analysis of Clinical Factors Related to Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
方中音, 梅金玉
临床医学进展Vol.14 No.6, 全文下载: PDF XML DOI:10.12677/acm.2024.1461869, June 28 2024
女性甲状腺乳头状癌患者共患乳腺癌的临床病理特征分析Analysis of Clinicopathological Characteristics of Papillary Thyroid Cancer with Breast Cancer in Female Patients
寻增欣, 孙梦媛, 张静文, 李文凤, 王 斐 科研立项经费支持
临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112856, December 20 2021
CK-19、CD-56在甲状腺乳头状癌和癌旁组织中的表达的研究进展Research Progress on the Expression of CK-19 and CD-56 in Papillary Thyroid Carcinoma and Para-Carcinoma Tissues
文 昊, 耿中利
临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122774, December 26 2023
甲状腺乳头状癌与桥本甲状腺炎关系研究进展Research Progress on the Relationship between Thyroid Papillary Carcinoma and Hashimoto’s Thyroiditis
樊艺璇, 张雪云
临床医学进展Vol.12 No.6, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.126808, June 21 2022
ADAR1和HMGA2在甲状腺乳头状癌中的表达及临床意义分析Expression and Clinical Significance of ADAR1 and HMGA2 in Papillary Thyroid Carcinoma
戚庆鑫, 张文伟, 秦作荣, 周智超, 王效军, 邱 杰
临床医学进展Vol.14 No.6, 全文下载: PDF XML DOI:10.12677/acm.2024.1461797, June 18 2024
BRAF V600E、p53、CD56、CK19、Galectin-3、TPO在247例甲状腺乳头状癌的表达与诊断价值Expression of BRAF V600E, p53, CD56, CK19, Galectin-3, TPO in 247 Cases of Papillary Thyroid Carcinoma and Its Diagnostic Value
胡诗梦, 王 敏
临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281044, August 8 2022